StonvexLoading…
StonvexStonvexStonvexCore line items from TR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $151.54M | $732.52M | $536.25M | $303.54M |
Operating Income | $23.21M | $100.94M | $67.55M | $35.18M |
Net Income | $17.66M | $100.05M | $71.26M | $35.60M |
EPS (Diluted) | $0.24 | $1.37 | $0.98 | $0.49 |
Total Assets | $1.25B | $1.25B | $1.23B | $1.18B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $113.05M | $127.17M | $78.89M | $120.52M |
Free Cash Flow OCF − CapEx | $3.29M | $96.35M | $35.37M | $-15.30M |
Shares Outstanding | 75.06M | 72.91M | 72.91M | 72.92M |